Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 08 Jan 2008
- First Look
First Look: January 8, 2008
to unaccounted capital flight. Download the paper: http://www.hbs.edu/research/pdf/07-074.pdf Cases & Course MaterialsAntegren: A Beacon of Hope Harvard Business School Case 408-025 The CEO of Biogen Idec faces a set of difficult decisions regarding a promising... View Details
Keywords: Martha Lagace
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and... View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 19 Oct 2015
- Research & Ideas
Business Research that Makes for Smarter Public Policy
Ginger Jin, of the Maryland Center for Economics and Policy, is just one example. They invited regulatory officials from several leading federal agencies, including the Department of Agriculture (USDA), Environmental Protection Agency (EPA), Food and View Details
Keywords: by Michael Blanding
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 31 Jan 2017
- First Look
First Look at New Research: January 31, 2017
Abstract—The Food and Drug Administration approves new medical devices after in-depth reviews of safety and effectiveness data. Some have advocated for shorter review times to encourage innovation. We evaluated whether regulatory review... View Details
Keywords: Carmen Nobel
- 21 Mar 2004
- Research & Ideas
Loyalty: Don’t Give Away the Store
you decide to focus your research on the grocery retail business? Rajiv Lal: The programs I see most often are the simple programs where you get a card, and use the card to get promotions. You see these in all types of retail business: grocery stores, View Details
- 15 Jan 2013
- First Look
First Look: January 15
KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the... View Details
Keywords: Sean Silverthorne
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche... View Details
Keywords: Sean Silverthorne
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that everyone is talking about. This is... View Details
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
chronic work stress, while only 36 percent reported their employers provided adequate support to manage it. According to the National Institute of Mental Health, some 6.7 percent of American adults experience "major depressive disorder; antidepressants are the most... View Details
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
system: Where are the best people and ideas in your field? "If you believe that knowledge is more and more globally distributed, chances are not all the best people work for you," he declared. Can you control the leakage of ideas? The patent system and... View Details
Keywords: by Jim Aisner
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
Source: Cecilie_Arcurs George Serafeim has a startling suggestion to fix the world’s biggest environmental, social, and governance (ESG) problems such as water pollution, deforestation, and wealth inequality: encourage companies within industries to do less competing... View Details
- 24 Jun 2014
- First Look
First Look: June 24
malaria-"at no profit"-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of... View Details
Keywords: Sean Silverthorne
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
profitability. In Chapter 6 we describe the work of drug company Cipla in India and telephone company China Mobile working in rural western China to bring affordable drugs, and smart telephone connections, respectively, to hundreds of... View Details
Keywords: by Martha Lagace
- 31 May 2016
- First Look
May 31, 2016
significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar... View Details
Keywords: Sean Silverthorne
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 10 Sep 2007
- Research & Ideas
High Note: Managing the Medici String Quartet
Robertson working for you as your key software developer, drug researcher, or designer, he would be a handful, to say the least. There are key people in these kinds of businesses, and they are what they are. One of the managing partners... View Details
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
for All published by the Harvard Business Review. [Image: Hispanolistic] Related Reading Germany May Have the Answer for Reducing Drug Prices What Hospitals Must Learn to Compete Making Health Insurance That Consumers Actually Like What... View Details